Beijing, China

Meiyan Yang

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Meiyan Yang: Innovator in Pharmaceutical Composition

Introduction

Meiyan Yang is a prominent inventor based in Beijing, China, known for his significant contributions to the field of pharmaceutical compositions. With a total of six patents to his name, Yang has focused on improving the solubility and effectiveness of various pharmaceutical compounds.

Latest Patents

Yang's latest patents include an injectable pharmaceutical composition of Tecovirimat and a preparation method thereof. This invention relates to a pharmaceutical composition for injection that comprises Tecovirimat as an active ingredient, cyclodextrin, and an additive. The composition enhances the solubility of Tecovirimat in water by utilizing cyclodextrin and meglumine in combination, which is more effective than using either component alone. Another notable patent is the oral pharmaceutical composition of Tecovirimat and its preparation method. Similar to the injectable version, this composition also improves the solubility of Tecovirimat by combining cyclodextrin and meglumine.

Career Highlights

Throughout his career, Meiyan Yang has worked with esteemed institutions such as the Institute of Pharmacology and Toxicology at the Academy of Military Medical Sciences in China. His work has significantly impacted the development of pharmaceutical formulations, particularly in enhancing drug solubility.

Collaborations

Yang has collaborated with notable colleagues, including Chunsheng Gao and Yuli Wang, who have contributed to his research and development efforts in the pharmaceutical field.

Conclusion

Meiyan Yang's innovative work in pharmaceutical compositions, particularly regarding Tecovirimat, showcases his dedication to advancing medical science. His contributions have the potential to improve treatment options and patient outcomes in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…